The immune system's involvement in obesity-driven type 2 diabetes

被引：134
|
作者：
Shu, Chengyi Jenny [1 ]
Benoist, Christophe [1 ]
Mathis, Diane [1 ]
机构：
[1] Harvard Univ, Div Immunol, Dept Microbiol & Immunobiol, Sch Med, Boston, MA 02115 USA
来源：
SEMINARS IN IMMUNOLOGY | 2012年 / 24卷 / 06期
关键词：
Obesity; Type; 2; diabetes; Inflammation; Adipose tissue; Insulin resistance; DIET-INDUCED OBESITY; REGULATORY T-CELLS; ADIPOSE-TISSUE MACROPHAGES; INDUCED INSULIN-RESISTANCE; NECROSIS-FACTOR-ALPHA; FREE FATTY-ACIDS; B-CELLS; ALTERNATIVE ACTIVATION; NLRP3; INFLAMMASOME; UNIQUE POPULATION;
D O I：
10.1016/j.smim.2012.12.001
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Type 2 diabetes is now a worldwide epidemic, strongly correlated with an elevated incidence of obesity. Obesity-associated adipose tissue inflammation is a major cause of the decreased insulin sensitivity seen in type 2 diabetes. Recent studies have shed light on the cross-talk between the immune system and organismal metabolism. This review discusses the connection between inflammation in adipose tissue and systemic insulin resistance, focusing on the roles of innate and adaptive immune cell subsets in the pathogenesis of this metabolic disease. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码：436 / 442
页数：7
相关论文
共 50 条
  • [1] Adipose Tissue-Resident Immune Cells in Obesity and Type 2 Diabetes
    Lu, Jingli
    Zhao, Junjie
    Meng, Haiyang
    Zhang, Xiaojian
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [2] State of the union between metabolism and the immune system in type 2 diabetes
    Nikolajczyk, B. S.
    Jagannathan-Bogdan, M.
    Shin, H.
    Gyurko, R.
    GENES AND IMMUNITY, 2011, 12 (04) : 239 - 250
  • [3] Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes
    Bellini, Lara
    Campana, Melanie
    Mahfouz, Rana
    Carlier, Aurelie
    Veret, Julien
    Magnan, Christophe
    Hajduch, Eric
    Le Stunff, Herve
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (08) : 1037 - 1050
  • [4] Immune regulators of inflammation in obesity-associated type 2 diabetes and coronary artery disease
    Strissel, Katherine J.
    Denis, Gerald V.
    Nikolajczyk, Barbara S.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2014, 21 (05) : 330 - 338
  • [5] Biomarkers and immune-modulating therapies for Type 2 diabetes
    Brooks-Worrell, Barbara
    Narla, Radhika
    Palmer, Jerry P.
    TRENDS IN IMMUNOLOGY, 2012, 33 (11) : 546 - 553
  • [6] Intrauterine programming of obesity and type 2 diabetes
    Fernandez-Twinn, Denise S.
    Hjort, Line
    Novakovic, Boris
    Ozanne, Susan E.
    Saffery, Richard
    DIABETOLOGIA, 2019, 62 (10) : 1789 - 1801
  • [7] Immune Cells Link Obesity-associated Type 2 Diabetes and Periodontitis
    Zhu, M.
    Nikolajczyk, B. S.
    JOURNAL OF DENTAL RESEARCH, 2014, 93 (04) : 346 - 352
  • [8] Mechanism of immune attack in the progression of obesity-related type 2 diabetes
    Wang, Hua-Wei
    Tang, Jun
    Sun, Li
    Li, Zhen
    Deng, Ming
    Dai, Zhe
    WORLD JOURNAL OF DIABETES, 2023, 14 (05) : 494 - 511
  • [9] Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD
    Reeves, Helen L.
    Zaki, Marco Y. W.
    Day, Christopher P.
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (05) : 1234 - 1245
  • [10] Is there a role for the adaptive immune system in pancreatic beta cell failure in type 2 diabetes?
    Westwell-Roper, Clara
    Ehses, Jan A.
    DIABETOLOGIA, 2014, 57 (03) : 447 - 450
12345